Dermatitis Herpetiformis: Celiac of the Skin

Dermatitis Herpetiformis Celiac of the Skin — scientific infographic poster

Dermatitis herpetiformis (DH) is celiac disease that shows up on your skin instead of — or in addition to — your gut. It is not "a rash that happens in celiac patients." It is the same disease, driven by the same gluten-triggered immune reaction, producing the same tissue transglutaminase antibodies, requiring the same lifelong gluten-free diet. The difference is where the antibody deposits choose to land: in DH, they accumulate in the tiny loops of connective tissue just under the top layer of skin (the dermal papillae), and the result is a maddeningly itchy, blistering eruption that can predate any digestive symptoms by years.

When someone has been told "your biopsy was negative for DH" but still itches every time they eat bread, the most common reason is that the sample was taken from the wrong spot. This page explains what DH is, how it is diagnosed, what dapsone does and does not do, why iodine is an under-recognized flare trigger, and why a strict gluten-free diet remains the only cure.

Table of Contents

  1. What Dermatitis Herpetiformis Is
  2. What the Rash Looks and Feels Like
  3. Pathogenesis: Why Gluten Attacks Your Skin
  4. Diagnosis: Direct Immunofluorescence Done Right
  5. The Gut You Can't See: Near-Universal Enteropathy
  6. Dapsone: Fast Relief, Real Risks
  7. Gluten-Free Diet: The Only Cure
  8. Iodine Sensitivity and Other Flare Triggers
  9. Differential Diagnosis: What It Isn't
  10. Key Research Papers
  11. PubMed Topic Searches
  12. Connections
  13. Featured Videos

What Dermatitis Herpetiformis Is

DH is an autoimmune skin disease that occurs almost exclusively in people with celiac disease. Roughly 10–15% of celiac patients develop DH at some point, and essentially 100% of DH patients have underlying celiac enteropathy on small-bowel biopsy — even when they have no stomach pain, no diarrhea, no bloating, nothing at all from the waist down.

The disease was first described by the American dermatologist Louis Duhring in 1884, which is why it is sometimes still called Duhring's disease. "Herpetiformis" refers to the shape of the eruption — grouped vesicles that resemble a herpes simplex outbreak — not any connection to the herpes virus. DH has nothing to do with any viral infection. It is purely immunologic, and the trigger is dietary gluten.

DH is more common in people of Northern European descent and affects slightly more men than women (the reverse of most celiac demographics). It is mostly a disease of adults: the mean age at onset is about 50, and most people are diagnosed in their 40s or 50s, though childhood and late-life onset both occur.

Finnish and British data show about one person with DH for every eight people with celiac disease. New DH cases are becoming rarer (about 2.7 per 100,000 people a year in Finland and 0.8 per 100,000 in the U.K.), while celiac diagnoses are rising. On a gluten-free diet the long-term outlook is excellent: the death rate of people with DH is even lower than that of the general population.

What the Rash Looks and Feels Like

The classic DH eruption has five features that, together, are almost diagnostic on sight:

One critical clue: DH almost never presents only on the trunk or only on the face. If the rash spares elbows, knees, and buttocks entirely, DH is unlikely.

Pathogenesis: Why Gluten Attacks Your Skin

The immune story connects the gut and the skin through a single family of enzymes called transglutaminases.

In celiac disease, gluten peptides in the small intestine are modified by tissue transglutaminase 2 (tTG or TG2). In HLA-DQ2 or DQ8 carriers, the immune system misreads this and produces immunoglobulin A (IgA) antibodies against tTG2. That is the foundation of classic celiac.

In DH, the dominant antibody target is a closely related enzyme: epidermal transglutaminase (eTG, also called TG3), expressed in the skin. The working model is that antibodies originally raised against tTG2 cross-react with TG3, or that TG3-specific immunoglobulin A is generated in parallel. Either way, IgA-TG3 immune complexes circulate in the blood and deposit in the dermal papillae — the fingertip-shaped projections of connective tissue just under the epidermis.

Those deposits activate complement (particularly C3) and recruit neutrophils to the tips of the papillae, where they release enzymes that separate the epidermis from the dermis. The result is a microscopic subepidermal blister filled with neutrophils, perfectly located at the top of each papilla. Multiply that by hundreds of papillae across an inflamed patch of skin and you get the clinically visible vesicle.

This is why the diet works: cut off gluten, the gut stops producing the antibody, and over months to years the skin deposits clear and new blisters stop forming.

Diagnosis: Direct Immunofluorescence Done Right

The gold standard for DH diagnosis is direct immunofluorescence (DIF) of perilesional skin. A small punch biopsy (3–4 mm) is taken and stained with a fluorescent antibody against human immunoglobulin A. In DH, the classic finding is granular immunoglobulin A deposits along the dermal-epidermal junction, concentrated at the tips of the dermal papillae. This pattern is essentially pathognomonic.

The single most common reason DH is missed: the biopsy was taken from the wrong place. The biopsy-site rules:

When a DIF comes back negative but the story sounds like DH, the key question is whether the biopsy came from lesional or perilesional skin. A lesional biopsy has to be repeated correctly before DH can be ruled out.

Supporting blood work. The blood tests that usually accompany DIF:

Testing is done while gluten is still being eaten. Serologies and skin DIF both become less reliable within weeks of eliminating gluten.

The Gut You Can't See: Near-Universal Enteropathy

When DH is confirmed, celiac small-bowel damage is almost certain whether or not there are gastrointestinal (GI) symptoms. Studies using duodenal biopsy in DH cohorts consistently find:

See the endoscopy and Marsh classification article for what those grades mean. The practical point: a duodenal biopsy is not necessary to diagnose DH (skin DIF is enough), but the same nutritional and bone-health surveillance as for any celiac patient does apply, because the underlying malabsorption is there. See nutritional deficiencies and bone health for the work-up.

It also cuts the other direction: skin symptoms often predate gastrointestinal symptoms by years or decades. Many DH patients describe chasing a mysterious itchy rash from dermatologist to dermatologist, being told it is eczema or scabies, and only discovering celiac when a sharp clinician finally orders DIF.

Dapsone: Fast Relief, Real Risks

A gluten-free diet is the definitive treatment, but it takes months to years to fully quiet the skin. In the meantime, the itch is unbearable. Dapsone (diaminodiphenyl sulfone) is the standard bridge therapy. It does not treat the underlying celiac disease — it suppresses the neutrophil-driven inflammation that forms each blister. Many patients notice dramatic itch relief within 24–72 hours of their first dose.

Typical dosing. Treatment usually starts at 25–50 mg orally once daily, titrated to the lowest dose that controls symptoms. Most adults settle at 50–100 mg/day, though some need up to 150–200 mg transiently. Children are dosed by weight (around 0.5–2 mg/kg/day). Once the gluten-free diet has worked for a year or two, the dapsone dose is tapered and usually stopped entirely.

Required before the first dose.

Required during therapy.

Other side effects to know. Peripheral neuropathy (usually motor, dose-dependent, reversible), dapsone hypersensitivity syndrome (fever, rash, hepatitis, eosinophilia — within the first 6 weeks; requires immediate drug cessation), and rarely psychosis.

If dapsone is not tolerated, alternatives include sulfapyridine (harder to obtain in the U.S.) and sulfasalazine. Topical steroids and antihistamines help with itch but do not control the eruption on their own.

Gluten-Free Diet: The Only Cure

A strict, lifelong gluten-free diet is the definitive treatment for DH. It is the only intervention that addresses the underlying antibody production. On a clean diet:

"Strict" means strict. Even trace gluten — a few crumbs from a shared toaster, oats processed in a wheat facility, a soy sauce splash on restaurant sushi — can reactivate the skin deposits and bring blisters back. Many DH patients are measurably more sensitive to cross-contamination than classic celiac patients are. See the gluten-free diet practical guide for kitchen setup, restaurant strategy, reading labels, and the surprising places gluten hides (lip balm, communion wafers, certain medications, beer, malt vinegar, some soy sauces, seitan, barley-based "natural flavor").

DH does not wear off. A 2019 study tested whether long remission brings gluten tolerance: 19 people with DH who had kept a gluten-free diet for an average of 23 years ate gluten again for up to 12 months. The rash came back in 15 of them (79%) after an average of 5.6 months, three more developed small-bowel damage without a rash, and only one showed no sign of relapse — 95% in all could not tolerate gluten.

If the rash relapses after months of apparent control, the first question is always "what changed in the diet?" — not "do I need more dapsone?" A food diary for two weeks plus a repeat tTG-IgA usually identifies the breach.

Iodine Sensitivity and Other Flare Triggers

DH has an unusual and under-appreciated trigger: dietary iodine. Iodine does not cause DH — gluten does — but in someone with established DH, a sudden iodine load can precipitate a flare even on a clean gluten-free diet. The mechanism is not fully understood; iodine appears to act as a non-specific amplifier of the neutrophil response in skin already primed by immunoglobulin A deposits.

High-iodine sources linked to flares without an obvious gluten exposure:

Once DH is stable, an iodine-restricted diet is not considered necessary; normal iodized salt and ordinary seafood intake are tolerated. During a flare, or before a computed tomography scan with contrast, a physician who knows about the DH can recognise an unexpected worsening for what it is.

Other triggers reported in case series include nonsteroidal anti-inflammatory drugs (occasional), stress, and occasionally hormonal shifts.

Differential Diagnosis: What It Isn't

Several common skin conditions look enough like DH to delay diagnosis. The most frequent imposters:

Any patient whose "eczema" concentrates on elbows, knees, and buttocks, itches violently, and has not responded to topical steroids fits the pattern that is worked up for DH.

Key Research Papers

  1. Reunala T, Salmi TT, Hervonen K, Kaukinen K, Collin P. Dermatitis herpetiformis: a common extraintestinal manifestation of coeliac disease. Nutrients. 2018;10(5):602. — doi:10.3390/nu10050602
  2. Salmi TT. Dermatitis herpetiformis. Clin Exp Dermatol. 2019;44(7):728–731. — PubMed PMID: 31093998
  3. Caproni M, Antiga E, Melani L, Fabbri P. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009;23(6):633–638. — doi:10.1111/j.1468-3083.2009.03188.x
  4. Zone JJ. Skin manifestations of celiac disease. Gastroenterology. 2005;128(4 Suppl 1):S87–S91. — doi:10.1053/j.gastro.2005.02.026
  5. Sárdy M, Kárpáti S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002;195(6):747–757. — doi:10.1084/jem.20011299
  6. Reunala T, Hervonen K, Salmi T. Dermatitis herpetiformis: an update on diagnosis and management. Am J Clin Dermatol. 2021;22(3):329–338. — PubMed PMID: 33432477
  7. Mansikka E, Hervonen K, Kaukinen K, et al. Gluten challenge induces skin and small bowel relapse in long-term gluten-free diet-treated dermatitis herpetiformis. J Invest Dermatol. 2019;139(10):2108–2114. — PubMed PMID: 30998982

Back to Table of Contents

PubMed Topic Searches

For deeper reading, the following PubMed searches return current peer-reviewed work on DH biology, diagnosis, and management:

  1. Dermatitis herpetiformis review articles
  2. DH and direct immunofluorescence technique
  3. Epidermal transglutaminase (TG3) autoantigen
  4. Dapsone therapy in dermatitis herpetiformis
  5. Gluten-free diet outcomes in DH
  6. DH and iodine sensitivity
  7. DH and small-bowel enteropathy
  8. HLA-DQ2/DQ8 in DH
  9. DH and lymphoma risk on and off diet
  10. Dapsone safety: G6PD and methemoglobin monitoring

Connections

Back to Table of Contents